The DCT OS Report: More than 95% of biopharma executives say we're not going back to a site-based-only development model. Learn more

News.

Science 37 related announcements, media, stories, and more.

Industry-veteran Elisa Cascade Joins Science 37<sup>®</sup> as Chief Product Officer; Chris Ceppi appointed Chief Technology Officer
Industry-veteran Elisa Cascade Joins Science 37® as Chief Product Officer; Chris Ceppi appointed Chief Technology Officer

Science 37, the Operating System for today’s more agile clinical trials, announced Elisa Cascade has joined Science 37 and its senior executive team as Chief Product Officer. Science 37 veter...

CONTINUE
Emily Rollins Appointed to Science 37<sup>®</sup> Board of Directors
Emily Rollins Appointed to Science 37® Board of Directors

Science 37, the Operating System for today’s more agile clinical trials, announced the appointment of Emily Rollins to the Company’s Board of Directors. Ms. Rollins will serve as the ch...

CONTINUE
Science 37<sup>®</sup>, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCE
Science 37®, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCE

Science 37, Inc., the Operating System for today’s agile clinical trials, announced today that it has completed its previously announced business combination with LifeSci Acquisition II Corp....

CONTINUE
Join Science 37<sup>®</sup> and a Panel of Industry Leaders for a Pragmatic Discussion about “What it Takes to Truly Empower Diversity in Clinical Trials”
Join Science 37® and a Panel of Industry Leaders for a Pragmatic Discussion about “What it Takes to Truly Empower Diversity in Clinical Trials”

Science 37’s Global Head, Diversity in Clinical Trials, Ryan Pack, will host a interactive discussion with leaders from Novartis, PPD, National Urban League and Colorectal Cancer Alliance on ...

CONTINUE
Science 37<sup>®</sup> and Foundation Medicine Partner to Enable Interventional Home-Based Clinical Trials in Oncology
Science 37® and Foundation Medicine Partner to Enable Interventional Home-Based Clinical Trials in Oncology

Science 37 and Foundation Medicine today announced a collaboration to enable decentralized clinical research in oncology that will optimize recruitment and enrollment, improve patient retention, an...

CONTINUE
Science 37<sup>®</sup>  Appoints Christine Pellizzari as Chief Legal Officer
Science 37® Appoints Christine Pellizzari as Chief Legal Officer

Science 37, pioneer of the Decentralized Clinical Trial Operating System™ (DCT OS), today announced that Christine Pellizzari has joined the senior executive team as Chief Legal Officer. In t...

CONTINUE
New Science 37<sup>®</sup>  Report: Nearly 100% of Biopharma Executives Expect Clinical Trial Decentralization to Increase Yet Lack Internal Capabilities to Operationalize
New Science 37® Report: Nearly 100% of Biopharma Executives Expect Clinical Trial Decentralization to Increase Yet Lack Internal Capabilities to Operationalize

Science 37, pioneer of the Decentralized Clinical Trial Operating System™ (DCT OS), today unveiled the DCT OS Report, which highlights the growing trend of decentralization in research and th...

CONTINUE
Science 37<sup>®</sup> to Become Publicly Listed via Merger with LifeSci Acquisition II Corp., Powering the Clinical Trial Operating System of the Future
Science 37® to Become Publicly Listed via Merger with LifeSci Acquisition II Corp., Powering the Clinical Trial Operating System of the Future

LOS ANGELES and NEW YORK, May 7, 2021 – Science 37, Inc. (“Science 37”), developer of the Decentralized Clinical Trial Operating System, an...

CONTINUE
PPD and Science 37<sup>®</sup> Strengthen Collaboration to  Advance Decentralized Clinical Trials and Accelerate Development
PPD and Science 37® Strengthen Collaboration to Advance Decentralized Clinical Trials and Accelerate Development

PPD, Inc., a leading global contract research organization (CRO), and Science 37, developer of the Decentralized Clinical Trial Operating System™ (DCT...

CONTINUE
Syneos Health<sup>®</sup> Partners with Science 37<sup>®</sup> to Transform Clinical Trials – Increasing Speed and Diversity
Syneos Health® Partners with Science 37® to Transform Clinical Trials – Increasing Speed and Diversity

Syneos Health® and Science 37 today announced a strategic partnership to enable enhanced decentralized clinical trial delivery. Together, Science 37 and Syneos Health will offer...

CONTINUE
Science 37<sup>®</sup> and Xperiome<sup>™</sup> Partner to Increase the Efficiency and Speed of Rare Disease Studies for Patients and Providers
Science 37® and Xperiome Partner to Increase the Efficiency and Speed of Rare Disease Studies for Patients and Providers

Science 37 announced today a partnership with Xperiome, a global rare disease healthtech company. The partnership further strengthens Science 37's capabilities to bring research directly to pat...

CONTINUE
Science 37<sup>®</sup> and Medgate Partner to Further Globalize Decentralized Clinical Trials
Science 37® and Medgate Partner to Further Globalize Decentralized Clinical Trials

Science 37 announced today a strategic partnership with Medgate, a leading international digital health and telemedicine company and operator of Europe’s largest telemedicine center run by ph...

CONTINUE
Page 1 of 3
123